PRODUCTS
An array of non-invasive solutions for diagnosis, screening and monitoring
LIVERFASt™ is a blood based diagnostic test that combines 10 biomarkers and algorithm technology to determine the fibrosis, activity and steatosis stages of the liver.
Biomarkers
- Alpha-2-Macroglobulin
- Haptoglobin
- Apolipoprotein A1
- Total Bilirubin
- GGT
- ALT (P5P)
- AST (P5P)
- Fasting Glucose
- Triglyceride
- Total Cholesterol
LIVERFACt is a component of LIVERFASt™ that utilizes only 6
out of the 10 biomarkers to provide results for fibrosis and
activity stages of the liver. LIVERFACt enables early
diagnosis of liver disease in patients with Hepatitis B and
Hepatitis C.
Biomarkers
- Alpha-2-Macroglobulin
- Haptoglobin
- Apolipoprotein A1
- Total Bilirubin
- GGT
- ALT (P5P)
SteatoTEST applies the similar 10 biomarkers that LIVERFASt™ utilizes and provides results for the staging of liver steatosis or also known as fatty liver.
Biomarkers
- Alpha-2-Macroglobulin
- Haptoglobin
- Apolipoprotein A1
- Total Bilirubin
- GGT
- ALT (P5P)
- AST (P5P)
- Fasting Glucose
- Triglyceride
- Total Cholesterol
LIVERFASt select is a risk stratification tool for fatty liver disease that utilizes a combination of basic blood biomarkers and algorithm technology.
Biomarkers
- Total Bilirubin
- GGT
- ALT (P5P)
- Fasting Glucose
- Triglyceride
- Total Cholesterol
HealthFACTR employs technology to predict risk – providing results for risks of coronary heart disease, stroke, diabetes and fatty liver disease.
Biomarkers
- LDL Cholesterol
- HDL Cholesterol
- Body Fat Percentage
- Triglyceride
- Total Cholesterol
